16 related articles for article (PubMed ID: 26505911)
1. Effects of Recombinant Circularly Permuted Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) (Recombinant Mutant Human TRAIL) in Combination with 5-Fluorouracil in Human Colorectal Cancer Cell Lines HCT116 and SW480.
Sun T; Zhu T; Liang X; Yang S; Zhao R
Med Sci Monit; 2018 Apr; 24():2550-2561. PubMed ID: 29695684
[TBL] [Abstract][Full Text] [Related]
2. Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.
Cholujova D; Bujnakova Z; Dutkova E; Hideshima T; Groen RW; Mitsiades CS; Richardson PG; Dorfman DM; Balaz P; Anderson KC; Jakubikova J
Br J Haematol; 2017 Dec; 179(5):756-771. PubMed ID: 29048129
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of rmhTRAIL and 17-AAG on the proliferation and apoptosis of multiple myeloma cells.
Wang J; Li Y; Sun W; Liu J; Chen W
Hematology; 2018 Oct; 23(9):620-625. PubMed ID: 29566599
[TBL] [Abstract][Full Text] [Related]
4. [Apoptosis of the adriamycin-resistant leukemia cell line induced by the recombinant mutant human TNF-related apoptosis-inducing ligand combined with arsenic trioxide].
Wang YR; Wen SP; Wang FX; Wen L; Yang BY; Yang JC; Zhang XJ; Yang SF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1055-9. PubMed ID: 18928594
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
Wu X; Shi J; Wu Y; Tao Y; Hou J; Meng X; Hu X; Han Y; Jiang W; Tang S; Zangari M; Tricot G; Zhan F
Cancer Biol Ther; 2010 Dec; 10(11):1201-14. PubMed ID: 20953137
[TBL] [Abstract][Full Text] [Related]
6. Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells.
Ge F; Lu XP; Zeng HL; He QY; Xiong S; Jin L; He QY
J Proteome Res; 2009 Jun; 8(6):3006-19. PubMed ID: 19364129
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the change in sphingolipids in the human multiple myeloma cell line U266 and gastric cancer cell line MGC-803 treated with arsenic trioxide.
Zou J; Ma X; Zhang G; Shen L; Zhou L; Yu Y; Zhu F; Chen Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1004():98-107. PubMed ID: 26454796
[TBL] [Abstract][Full Text] [Related]
8. Effects and mechanism of arsenic trioxide in combination with rmhTRAIL in multiple myeloma.
Zhou H; Li J; Jian Y; Chen T; Deng H; Zhang J; Zeng H; Shan Z; Chen W
Exp Hematol; 2016 Feb; 44(2):125-131.e11. PubMed ID: 26505911
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
